Effect of liposome membranes on disaggregation of amyloid β fibrils by dopamine

Biochemical Engineering Journal

Volumn 71, Issue , 2013, Pages 118-126

  Vu, Huong Thi ^a   Shimanouchi, Toshinori ^a   Ishikawa, Daisuke ^a   Matsumoto, Tadaharu ^a   Yagi, Hisashi ^a   Goto, Yuji ^a   Umakoshi, Hiroshi ^a   Kuboi, Ryoichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid beta fibrils; Catecholamines; Disaggregation; Liposome

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID BETAS; BOUND WATERS; CATECHOLAMINES; DISAGGREGATION; FIBRIL FORMATION; LIPOSOME MEMBRANES; MEDICAL TREATMENT; MEMBRANE SURFACE;

AMINES; GLYCOPROTEINS; NEUROPHYSIOLOGY;

LIPOSOMES;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DOPAMINE; LIPOSOME; QUININE;

ALZHEIMER DISEASE; ARTICLE; DISPERSION; LIPID COMPOSITION; LIPID MEMBRANE; LIPID OXIDATION; LIPID RAFT; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84872035920     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2012.12.012     Document Type: Article

References (46)

1. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
2. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 1991, 6:487-498.
3. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996, 16:921-932.
4. Dahlgren K.N., Manelli A.M., Stine W.B.J., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277:32046-32053.
5. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008, 155:725-737.
6. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
7. Li J., Zhu M., Manning-Bog A.B., Monte D.A.D., Fink A.L. Dopamine and l-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease. FASEB J. 2004, 18:962-964.
8. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., Hoshino M., Naiki H. Inhibitors of amyloid beta protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 2007, 1768:122-130.
9. Durairajan S.S.K., Yuan Q., Xie L., Chan W.S., Kum W.F., Koo I., Liu C., Song Y., Huang J.D., Klein W.L., Li M. Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxicity. Neurochem. Int. 2008, 52:741-750.
10. 1-11 antibody binds to different β-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J. Biol. Chem. 2007, 282:22376-22386.
11. Vu H.T., Shimanouchi T., Yagi H., Umakoshi H., Goto Y., Kuboi R. Catechol derivatives inhibit the fibril formation of amyloid-β peptides. J. Biosci. Bioeng. 2010, 109:629-634.
12. Ghanta J., Shen C.L., Kiessling L.L., Murphy R.M. A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 1996, 271:29525-29528.
13. Soto C., Sigurdsson E.M., Morelli L., Kumar A., Castano E.M., Frangione B. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implication for Alzheimer's therapy. Nat. Med. 1998, 4:822-826.
14. Webster S., Bradt B., Rogers J., Cooper N. Aggregation-state dependent activation of the classical complement pathway by the amyloid-β peptide. J. Neurochem. 1997, 69:388-398.
15. 2-microglobulin fragment by laser beam irradiation. J. Biol. Chem. 2009, 284:1009-1017.
16. Yagi H., Ozawa D., Sakurai K., Kawakami T., Kuyama H., Nishimura O., Shimanouchi T., Kuboi R., Naiki H., Goto Y. Laser-induced propagation and destruction of amyloid β(1-40) fibrils. J. Biol. Chem. 2010, 285:19660-19667.
17. Okada T., Wakabayashia M., Ikeda K., Matsuzaki K. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. 2007, 371:481-489.
18. Le Q.T., Umakoshi H., Shimanouchi T., Kuboi R. Liposome-recruited activity of oxidized and fragmented superoxide dismutase. Langmuir 2008, 24:350-354.
19. Le Q.T., Umakoshi H., Shimanouchi T., Kuboi R. Liposome membrane can act like molecular and metal chaperones for oxidized and fragmented superoxide dismutase. Enzyme Microb. Technol. 2009, 44:101-106.
20. Avdulov N.A., Chochina S.V., Igbavboa U., Warden C.S., Vassiliev A.V., Wood W.G. Lipid binding to amyloid β-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 1997, 69:1746-1752.
21. Yamamoto I., Konto A., Handa T., Miyajima K. Regulation of phospholipase D activity by neutral lipids in egg-yolk phosphatidylcholine small unilamellar vesicles and by calcium ion in aqueous medium. Biochim. Biophys. Acta 1995, 1233:21-26.
22. Yoshimoto N., Yoshimoto M., Yasuhara K., Shimanouchi T., Umakoshi H., Kuboi R. Evaluation of temperature and guanidine hydrochloride-induced protein-liposome interactions by using immobilized liposome chromatography. Biochem. Eng. J. 2006, 29:174-181.
23. Shimanouchi T., Ohnishi R., Kitaura N., Umakoshi H., Kuboi R. Copper-mediated growth of amyloid β fibrils in the presence of oxidized and negatively charged liposomes. J. Biosci. Bioeng. 2011, 112:611-615.
24. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nasser A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 1989, 30:627-630.
25. Andersen C.B., Yagi H., Manno M., Martorana V., Ban T., Christiansen G., Otzen D.E., Goto Y., Rischel C. Branching in amyloid fibril growth. Biophys. J. 2009, 96:1529-1536.
26. Noda M., Shimanouchi T., Suzuki H., Okuyama M., Kuboi R. Analysis of complex permittivity of liposome for its biochemical dynamics up to 30GHz range. IEEE Microw. Theor. Tech. 2006, 54(6):1983-1986.
27. Shimanouchi T., Sasaki S., Hiroiwa A., Yoshimoto N., Miyagawa K., Umakoshi H., Kuboi R. Relationship between the mobility of phosphocholine headgroups of liposomes and the hydrophobicity at the membrane interface: a characterization with spectrophotometric measurements. Colloids Surf. B 2011, 88:221-230.
28. 2-microglobulin and hen egg-white lysozyme into amyloid fibrils. J. Mol. Biol. 2007, 372:981-991.
29. Martins I.C., Kuperstein I., Wilkinson H., Maes E., Vanbrabant M., Jonckheere W., Gelder P.V., Hartmann D., D'Hooge R., Strooper B.D., Schymkowitz J., Rousseau F. Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 2008, 27:224-233.
30. Shimanouchi T., Shimauchi N., Nishiyama K., Vu T.H., Yagi H., Goto Y., Umakoshi H., Kuboi R. Characterization of amyloid-β fibrils with aqueous two-phase system: implications of fibrils formation. Solvent Extr. Res. Dev. Jpn. 2010, 17:122-128.
31. Tse D.C.S., McCreery R.L., Adams R.N. Potential oxidative pathways of brain catecholamines. J. Med. Chem. 1976, 19:37-40.
32. Opazo C., Huang X., Cherny R.A., Moir R.D., Roher A.E., White A.R., Cappai R., Masters C.L., Tanzi R.E., Inestrosa N.C., Bush A.I. Metalloenzyme-like activity of Alzheimer's disease β-amyloid. J. Biol. Chem. 2002, 277(43):40302-40308.
33. Shimanouchi T., Tasaki M., Vu T.H., Ishii H., Yoshimoto N., Umakoshi H., Kuboi R. Aβ/Cu-oxidation of cholesterol on liposome membrane. J. Biosci. Bioeng. 2009, 109:145-148.
34. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005, 307:262-265.
35. Antzutkin O.N., Leapman R.D., Balbach J.J., Tycko R. Supramolecular structural constraints on Alzheimer's β-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 2002, 41:15436-15450.
36. Petkova A.T., Ishii Y., Balbach J.J., Antzukin O.N., Leapman R.D., Delaglio F., Tycko R. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16742-16747.
37. Fernandez A. What factor drives the fibrillogenic association of β-sheets. FEBS Lett. 2005, 579:6635-6640.
38. Wu C., Lei H., Duan Y. Formation of partially ordered oligomers of amyloidogenic hexapeptide (NFGAIL) in aqueous solution observed in molecular dynamics simulations. Biophys. J. 2004, 87:3000-3009.
39. Klosgen B., Reichle C., Kohlsmann S., Kramer K.D. Dielectric spectroscopy as a sensor of membrane headgroup mobility and hydration. Biophys. J. 1996, 71:3251-3260.
40. Franks F. Water: A Comprehensive Treatise 1973, vol. 3. Plenum Press, New York.
41. Koppaka V., Paul C., Murray I.V.J., Axelsen P.H. Early synergy between A beta 42 and oxidatively damaged membranes in promoting amyloid fibril formation by A beta 40. J. Biol. Chem. 2003, 278:36277-36384.
42. Chauhan A., Ray I., Chauhan V.P.S. Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids. Neurochem. Res. 2000, 25:423-429.
43. Ikeda K., Matsuzaki K. Driving force of binding of amyloid β-protein to lipid bilayers. Biochem. Biophys. Res. Commun. 2008, 370:525-529.
44. Tahara Y., Fujiyoshi Y. A new method to measure bilayer thickness: cryo-electron microscopy of frozen hydrated liposomes and image simulation. Micron 1994, 25:141-149.
45. 1H nuclear magnetic resonance method for investigating the phospholipase D-catalyzed hydrolysis of phosphatidylcholine in liposomes. Anal. Biochem. 1996, 240:37-47.
46. Vechett G.F., de Arcuri B.F., Posse E., Arrondo J.L., Morero R.D. Aggregation, fusion and aqueous content release from liposomes induced by lysozyme derivatives: effect on the lytic activity. Mol. Membr. Biol. 1997, 14:137-142.